| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18821651 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 105 journal articles in the PubMed database | Email to a friend | | |
| Curkendall S, Patel V, Gleeson M, et al.
Compliance with biologic therapies for rheumatoid arthritis: do patient out-of-pocket payments matter? [Journal Article, Research Support, Non-U.S. Gov't]
Arthritis Rheum 2008 Oct 15; 59(10):1519-26.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Weycker D, Yu EB, Woolley JM, et al.
Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged > or =65 years with rheumatoid arthritis. [Journal Article]
Clin Ther 2005 May; 27(5):646-56.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tang B, Rahman M, Waters HC, et al.
Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis. [Journal Article]
Clin Ther 2008 Jul; 30(7):1375-84.
Abstract | Full Citation | Find Related Articles | | Chen YF, Jobanputra P, Barton P, et al.
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. [Journal Article]
Health Technol Assess 2006 Nov; 10(42):1-248.
Abstract | Full Citation | Find Related Articles | | Nuijten MJ, Engelfriet P, Duijn K, et al.
A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis. [Journal Article]
Pharmacoeconomics 2001; 19(10):1051-64.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kievit W, Adang EM, Fransen J, et al.
The effectiveness and medication costs of three anti-TNF agents{alpha} in the treatment of rheumatoid arthritis from prospective clinical practice data. [JOURNAL ARTICLE]
Ann Rheum Dis 2008 Jan 3.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | DeWitt EM, Glick HA, Albert DA, et al.
Medicare coverage of tumor necrosis factor alpha inhibitors as an influence on physicians' prescribing behavior. [Journal Article]
Arch Intern Med 2006 Jan 9; 166(1):57-63.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Wu E, Chen L, Birnbaum H, et al.
Cost of care for patients with rheumatoid arthritis receiving TNF-antagonist therapy using claims data. [JOURNAL ARTICLE]
Curr Med Res Opin 2007 Jun 22.
Abstract | Full Citation | Find Related Articles | | Ollendorf DA, Peterson AN, Doyle J, et al.
Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population. [Journal Article]
Am J Manag Care 2002 May; 8(7 Suppl):S203-13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
